Navigation Links
Renewable Fuel Chopper Raffle Nets $113,000 for American Lung Association Clean Air Choice Program
Date:9/19/2007

an Lung Association of Iowa at (515) 309-9507.

The Iowa Clean Air Choice Team is a group consisting of General Motors, Iowa Biodiesel Board, Iowa Corn Promotion Board, Iowa Soybean Association, Iowa Renewable Fuels Association, Kum & Go, Iowa Farm Bureau Federation, Siouxland Energy & Livestock Cooperative, the National Ethanol Vehicle Coalition and the American Lung Association of Iowa.


'/>"/>
SOURCE American Lung Association of Iowa
Copyright©2007 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related medicine news :

1. Renewable Oocytes of Mice created hope in Human Fertility Treatment
2. Abstain from sex- the latest mantra of American teens
3. Clintons new problem - Is the outgoing American president suffering from skin cancer?
4. American scientists alter gene makeup of babies
5. FDA attacks American Red Cross for blood violations
6. Poll Finds Many Americans Misinformed About Cancer
7. Poll Finds Many Americans Misinformed About Cancer
8. Hypertension Drug of Choice for African Americans
9. 38 million Americans including 14 million children left to combat hunger
10. Americans Consume Far Too Much Salt and Sodium
11. Americans Growing Out Of Shape
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Sangart, Inc. Initiates Phase IIa Study of Oxygen Therapeutic Agent MP4OX in Severe Trauma Patients With Hemorrhagic Shock 2Sangart, Inc. Initiates Phase IIa Study of Oxygen Therapeutic Agent MP4OX in Severe Trauma Patients With Hemorrhagic Shock 3FDA Launches Orphan Drug Workshop at KGI 2BioCryst Pharmaceuticals Elects Charles A. Sanders to its Board of Directors 2BioCryst Pharmaceuticals Elects Charles A. Sanders to its Board of Directors 3BioCryst Pharmaceuticals Elects Charles A. Sanders to its Board of Directors 4Angiotech Pharmaceuticals announces FDA 510 28k 29 clearance of the Option 28TM 29 Inferior Vena Cava Filter 12515 1Angiotech Pharmaceuticals announces FDA 510 28k 29 clearance of the Option 28TM 29 Inferior Vena Cava Filter 12515 2Angiotech Pharmaceuticals announces FDA 510 28k 29 clearance of the Option 28TM 29 Inferior Vena Cava Filter 12515 3Angiotech Pharmaceuticals announces FDA 510 28k 29 clearance of the Option 28TM 29 Inferior Vena Cava Filter 12515 4Angiotech Pharmaceuticals announces FDA 510 28k 29 clearance of the Option 28TM 29 Inferior Vena Cava Filter 12515 5Angiotech Pharmaceuticals announces FDA 510 28k 29 clearance of the Option 28TM 29 Inferior Vena Cava Filter 12515 6Enrollment in Delcaths Pivotal Phase III Metastatic Melanoma Clinical Trial Achieves Seventy Five Percent Accrual 4559 1Enrollment in Delcaths Pivotal Phase III Metastatic Melanoma Clinical Trial Achieves Seventy Five Percent Accrual 4559 2Enrollment in Delcaths Pivotal Phase III Metastatic Melanoma Clinical Trial Achieves Seventy Five Percent Accrual 4559 3Diamyd 28R 29 Phase III Study Approved for Younger Patients in the US 12511 1Diamyd 28R 29 Phase III Study Approved for Younger Patients in the US 12511 2